Showing results (291-300 of 381) with videos related to

Sort By:
Pageof 39
Cancers|December 24, 2021
Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of GlioblastomaJennifer Batalla-Covello, Hoi Wa Ngai, Linda Flores, et al.
Virology Journal|August 23, 2008
Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approachQiana L Matthews, PingAr Yang, Qi Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2003
A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal modelAkseli Hemminki, Anna Kanerva, Eric J Kremer, et al.
Cancer Gene Therapy|April 30, 2003
Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroidsJohn T Lam, Gerd J Bauerschmitz, Anna Kanerva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activationGuo Zhang, Margaret A Park, Clint Mitchell, et al.
Molecular Imaging|October 3, 2009
Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancerKristopher J Kimball, Angel A Rivera, Kurt R Zinn, et al.
Frontiers in Immunology|November 19, 2019
Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus DiseaseRebecca M Broeckel, Nicole Haese, Takeshi Ando, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2023
Adenoviral vectors infect B lymphocytes in vivoPaul J Rice-Boucher, Samir Andrade Mendonça, Aluet Borrego Alvarez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Cancer Research|January 28, 2010
PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cellsAdly Yacoub, Hossein A Hamed, Jeremy Allegood, et al.
Pageof 39